- Home
- CLOV vs PRAX Comparison
CLOV vs PRAX Comparison
Compare CLOV & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLOV
- PRAX
- Stock Information
- Founded
- CLOV 2014
- PRAX 2015
- Country
- CLOV United States
- PRAX United States
- Employees
- CLOV N/A
- PRAX N/A
- Industry
- CLOV Medical Specialities
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- CLOV Health Care
- PRAX Health Care
- Exchange
- CLOV Nasdaq
- PRAX Nasdaq
- Market Cap
- CLOV 922.8M
- PRAX 920.7M
- IPO Year
- CLOV N/A
- PRAX 2020
- Fundamental
- Price
- CLOV $3.09
- PRAX $58.85
- Analyst Decision
- CLOV
- PRAX Strong Buy
- Analyst Count
- CLOV 0
- PRAX 9
- Target Price
- CLOV N/A
- PRAX $144.11
- AVG Volume (30 Days)
- CLOV 11.6M
- PRAX 245.6K
- Earning Date
- CLOV 11-04-2024
- PRAX 11-05-2024
- Dividend Yield
- CLOV N/A
- PRAX N/A
- EPS Growth
- CLOV N/A
- PRAX N/A
- EPS
- CLOV N/A
- PRAX N/A
- Revenue
- CLOV $2,089,870,000.00
- PRAX $1,771,000.00
- Revenue This Year
- CLOV N/A
- PRAX N/A
- Revenue Next Year
- CLOV $5.80
- PRAX N/A
- P/E Ratio
- CLOV N/A
- PRAX N/A
- Revenue Growth
- CLOV N/A
- PRAX 20.97
- 52 Week Low
- CLOV $0.61
- PRAX $13.01
- 52 Week High
- CLOV $3.82
- PRAX $67.21
- Technical
- Relative Strength Index (RSI)
- CLOV 60.85
- PRAX 61.83
- Support Level
- CLOV $2.47
- PRAX $55.97
- Resistance Level
- CLOV $2.99
- PRAX $59.99
- Average True Range (ATR)
- CLOV 0.23
- PRAX 3.48
- MACD
- CLOV -0.03
- PRAX 0.55
- Stochastic Oscillator
- CLOV 58.73
- PRAX 95.03
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. Operating in two segments, Insurance and Non-Insurance, Clover Health offers PPO and HMO plans to Medicare Advantage members in multiple states through its Insurance segment. In the Non-Insurance segment, the company participates in the ACO REACH Model. The majority of revenue is generated from the insurance segment, reflecting the significance of its healthcare insurance offerings.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.